A multicentre, randomised, double-masked, sham controlled study of intravitreal OPT-302 in combination with ranibizumab, for wet AMD

    Activity: Talk or presentation › Oral presentation

    Period15 Sept 2019
    Event titleRetina Society Annual Congress
    Event typeConference
    LocationLondon, United KingdomShow on map
    Degree of RecognitionInternational